13F HOLDINGS REPORT
Frazier Life Sciences Management, L.P.
Quarter ended Q4 2024 · Filed February 18, 2025 · Accession 0001892134-25-000001
Total Value
$2.41B
Positions
50
Other Managers
0
Confidential Omitted
No
Holdings (50)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 15,916,418 | $409.1M | 16.98% |
| 2 | MIRUM PHARMACEUTICALS INC | MIRM | 6,570,392 | $271.7M | 11.28% |
| 3 | VERONA PHARMA PLC | 925050106 | 3,383,950 | $157.2M | 6.52% |
| 4 | KRYSTAL BIOTECH INC | KRYS | 788,460 | $123.5M | 5.13% |
| 5 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 8,785,284 | $122.4M | 5.08% |
| 6 | DISC MEDICINE INC | IRON | 1,754,834 | $111.3M | 4.62% |
| 7 | MBX BIOSCIENCES INC | MBX | 5,985,347 | $110.3M | 4.58% |
| 8 | RHYTHM PHARMACEUTICALS INC | RYTM | 1,869,808 | $104.7M | 4.34% |
| 9 | BRIDGEBIO PHARMA INC | BBIO | 3,800,457 | $104.3M | 4.33% |
| 10 | TARSUS PHARMACEUTICALS INC | TARS | 1,587,527 | $87.9M | 3.65% |
| 11 | PHATHOM PHARMACEUTICALS INC | PHAT | 10,109,279 | $82.1M | 3.41% |
| 12 | ERASCA INC | ERAS | 19,391,687 | $48.7M | 2.02% |
| 13 | VAXCYTE INC | PCVX | 539,405 | $44.2M | 1.83% |
| 14 | TREVI THERAPEUTICS INC | TRVI | 10,664,774 | $43.9M | 1.82% |
| 15 | REVOLUTION MEDICINES INC | RVMDW | 997,455 | $43.6M | 1.81% |
| 16 | KALVISTA PHARMACEUTICALS INC | KALV | 4,887,867 | $41.4M | 1.72% |
| 17 | AGIOS PHARMACEUTICALS INC | AGIO | 1,069,754 | $35.2M | 1.46% |
| 18 | EDGEWISE THERAPEUTICS INC | EWTX | 1,271,245 | $33.9M | 1.41% |
| 19 | SOLENO THERAPEUTICS INC | SLNO | 699,159 | $31.4M | 1.30% |
| 20 | ORIC PHARMACEUTICALS INC | ORIC | 3,888,238 | $31.4M | 1.30% |
| 21 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 658,715 | $27.7M | 1.15% |
| 22 | SAVARA INC | SVRA | 8,660,379 | $26.6M | 1.10% |
| 23 | CG ONCOLOGY INC | CGON | 770,000 | $22.1M | 0.92% |
| 24 | HILLEVAX INC | 43157M102 | 10,617,062 | $22.0M | 0.91% |
| 25 | ANAPTYSBIO INC | ANABV | 1,573,719 | $20.8M | 0.86% |
| 26 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,479,025 | $18.6M | 0.77% |
| 27 | ASCENDIS PHARMA A/S | ASND | 133,333 | $18.4M | 0.76% |
| 28 | MEREO BIOPHARMA GROUP PLC | MREO | 5,097,779 | $17.8M | 0.74% |
| 29 | ALKERMES PLC | ALKS | 601,129 | $17.3M | 0.72% |
| 30 | MERUS N V | N5749R100 | 373,100 | $15.7M | 0.65% |
| 31 | IMMATICS N.V | IMTX | 2,147,911 | $15.3M | 0.63% |
| 32 | PLIANT THERAPEUTICS INC | PLRX | 1,120,803 | $14.8M | 0.61% |
| 33 | DESIGN THERAPEUTICS INC | DSGN | 1,953,547 | $12.1M | 0.50% |
| 34 | ORUKA THERAPEUTICS INC | ORKA | 583,327 | $11.3M | 0.47% |
| 35 | AUTOLUS THERAPEUTICS PLC | AUTL | 4,623,324 | $10.9M | 0.45% |
| 36 | MACROGENICS INC | MGNX | 3,175,665 | $10.3M | 0.43% |
| 37 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 689,655 | $8.7M | 0.36% |
| 38 | ACADIA PHARMACEUTICALS INC | ACAD | 470,338 | $8.6M | 0.36% |
| 39 | SILENCE THERAPEUTICS PLC | SLNCF | 1,148,591 | $7.9M | 0.33% |
| 40 | PALVELLA THERAPEUTICS INC NE | PVLA | 653,892 | $7.8M | 0.33% |
| 41 | 89BIO INC | 282559103 | 1,000,000 | $7.8M | 0.32% |
| 42 | COGENT BIOSCIENCES INC | COGT | 936,576 | $7.3M | 0.30% |
| 43 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 500,333 | $7.1M | 0.30% |
| 44 | LEXEO THERAPEUTICS INC | LXEO | 955,515 | $6.3M | 0.26% |
| 45 | ALLOGENE THERAPEUTICS INC | ALLO | 2,867,750 | $6.1M | 0.25% |
| 46 | ARVINAS INC | ARVN | 285,331 | $5.5M | 0.23% |
| 47 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,069,244 | $5.0M | 0.21% |
| 48 | ELEDON PHARMACEUTICALS INC | ELDN | 1,176,735 | $4.8M | 0.20% |
| 49 | ELEVATION ONCOLOGY INC | 28623U101 | 5,993,579 | $3.4M | 0.14% |
| 50 | IMMUNOCORE HLDGS PLC | IMCR | 108,762 | $3.2M | 0.13% |